As a result, the interaction of VEGF with Flt-1 (VEGFR-1) and KDR (VEGFR-2) receptors on the surface of the endothelial cells is inhibited, which leads to the reduction of vascularization and inhibition of cancer growth. The gene discussed is KDR; the disease is cancer.